ACUTE GOUTY ARTHRITIS
Clinical trials for ACUTE GOUTY ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new ACUTE GOUTY ARTHRITIS trials appear
Sign up with your email to follow new studies for ACUTE GOUTY ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New IV drug aims to tame gout flare pain in hours
Symptom relief Recruiting nowThis Phase 2 trial tests punarlimab, a new IV drug, against a standard steroid injection for quick relief of acute gouty arthritis pain. About 170 adults with frequent gout flares will receive a single dose and report their pain levels over 72 hours. The goal is to see if punarli…
Matched conditions: ACUTE GOUTY ARTHRITIS
Phase: PHASE2 • Sponsor: TJ Biopharma Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New gout drug aims to beat pain faster than standard treatment
Symptom relief Recruiting nowThis Phase 2 trial tests an experimental drug called ABP-745 against colchicine (a standard gout medicine) and a placebo in 380 adults with acute gout flares. The goal is to see if ABP-745 reduces pain and swelling better than current options. Participants will take tablets and r…
Matched conditions: ACUTE GOUTY ARTHRITIS
Phase: PHASE2 • Sponsor: Atom Therapeutics Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC